tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RAPT Stock Latest News

Rapt Therapeutics Advances Food Allergy Treatment with RPT904 Study
Company AnnouncementsRapt Therapeutics Advances Food Allergy Treatment with RPT904 Study
24h ago
RAPT
RAPT Therapeutics Announces Major Public Stock Offering
PremiumCompany Announcements
RAPT Therapeutics Announces Major Public Stock Offering
2d ago
8K
RAPT
Rapt Therapeutics 8.333M share Spot Secondary priced at $30.00
PremiumThe Fly
Rapt Therapeutics 8.333M share Spot Secondary priced at $30.00
3d ago
RAPT
Rapt Therapeutics announces common stock offering, no amount given
PremiumThe Fly
Rapt Therapeutics announces common stock offering, no amount given
4d ago
RAPT
Rapt Therapeutics price target raised to $48 from $38 at Wells Fargo
PremiumThe Fly
Rapt Therapeutics price target raised to $48 from $38 at Wells Fargo
4d ago
RAPT
Rapt Therapeutics price target raised to $60 from $41 at Clear Street
PremiumThe FlyRapt Therapeutics price target raised to $60 from $41 at Clear Street
5d ago
RAPT
RAPT Therapeutics Reports Positive Phase 2 Trial Results
Premium
Company Announcements
RAPT Therapeutics Reports Positive Phase 2 Trial Results
5d ago
8K
RAPT
Rapt Therapeutics price target raised to $58 from $35 at Barclays
Premium
The Fly
Rapt Therapeutics price target raised to $58 from $35 at Barclays
5d ago
RAPT
RAPT Therapeutics’ Promising Phase 2 Results and Strategic Advancements Drive Buy Rating
PremiumRatings
RAPT Therapeutics’ Promising Phase 2 Results and Strategic Advancements Drive Buy Rating
5d ago
RAPT
JPMorgan upgrades Rapt Therapeutics on ‘compelling’ CSU data
PremiumThe Fly
JPMorgan upgrades Rapt Therapeutics on ‘compelling’ CSU data
5d ago
RAPT
Rapt Therapeutics upgraded to Overweight from Neutral at JPMorgan
PremiumThe Fly
Rapt Therapeutics upgraded to Overweight from Neutral at JPMorgan
5d ago
RAPT
RAPT Therapeutics trading resumes
PremiumThe Fly
RAPT Therapeutics trading resumes
5d ago
RAPT
RAPT Therapeutics trading halted, volatility trading pause
PremiumThe FlyRAPT Therapeutics trading halted, volatility trading pause
5d ago
RAPT
Rapt Therapeutics, Jeyou announce data from Phase 2 trial of RPT904
Premium
The Fly
Rapt Therapeutics, Jeyou announce data from Phase 2 trial of RPT904
5d ago
RAPT
Rapt Therapeutics initiated with an Overweight at Barclays
Premium
The Fly
Rapt Therapeutics initiated with an Overweight at Barclays
12d ago
RAPT
RAPT Therapeutics: Anticipated Catalysts and Growth Potential Drive Buy Rating
PremiumRatings
RAPT Therapeutics: Anticipated Catalysts and Growth Potential Drive Buy Rating
15d ago
RAPT
Rapt Therapeutics price target raised to $41 from $24 at Clear Street
PremiumThe Fly
Rapt Therapeutics price target raised to $41 from $24 at Clear Street
26d ago
RAPT
Rapt Therapeutics: FDA clears IND application for Phase 2b trial of RPT904
PremiumThe Fly
Rapt Therapeutics: FDA clears IND application for Phase 2b trial of RPT904
26d ago
RAPT
Leerink upgrades Rapt Therapeutics on food allergy opportunity for RPT904
PremiumThe Fly
Leerink upgrades Rapt Therapeutics on food allergy opportunity for RPT904
29d ago
RAPT
Rapt Therapeutics upgraded to Outperform from Market Perform at Leerink
PremiumThe FlyRapt Therapeutics upgraded to Outperform from Market Perform at Leerink
29d ago
RAPT
Rapt Therapeutics price target raised to $9 from $8 at UBS
Premium
The Fly
Rapt Therapeutics price target raised to $9 from $8 at UBS
2M ago
RAPT
Promising Potential of RAPT Therapeutics’ RPT904 Drives Buy Rating
Premium
Ratings
Promising Potential of RAPT Therapeutics’ RPT904 Drives Buy Rating
3M ago
RAPT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >